Item 5.07 Submission of Matters to a Vote of Security Holders

The following proposals were submitted to the stockholders of Arrowhead Pharmaceuticals, Inc. (the "Company") at the 2022 Annual Meeting of Stockholders held on March 17, 2022.



     •    To elect seven directors to serve as members of the Company's Board of
          Directors until the next Annual Meeting or until their successors are
          elected;



     •    To approve, on an advisory (non-binding) basis, of the compensation of
          the Company's named executive officers;



  •   To approve the Company's Non-Employee Director Compensation Plan; and



     •    To ratify the selection of Rose Snyder & Jacobs as independent auditors
          of the Company for the fiscal year ended September 30, 2022.

As of January 21, 2022, the record date for the Annual Meeting, the Company had 105,448,417 shares of its common stock outstanding and entitled to vote. At the Annual Meeting 89,738,550 shares were present in person or represented by proxy and entitled to vote. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below:



Election of Directors

NAME                       FOR            AGAINST         ABSTAIN       NON VOTES
Christopher Anzalone     68,581,047          803,556       195,619       20,158,328
Douglass Given           67,565,311        1,889,395       125,516       20,158,328
Mauro Ferrari            24,257,754       44,444,641       877,827       20,158,328
Michael S. Perry         29,372,150       39,753,834       454,238       20,158,328
William Waddill          25,926,483       42,741,598       912,141       20,158,328
Marianne De Backer       39,901,384       29,329,002       349,836       20,158,328
Adeoye Olukoton          39,368,271       29,230,260       981,691       20,158,328

Advisory Vote to Approve Executive Compensation

14,213,202 FOR 54,813,812 AGAINST 553,208 ABSTAIN 20,158,328 NON VOTES

Approval of the Non-Employee Director Compensation Plan

16,045,691 FOR 52,535,735 AGAINST 998,796 ABSTAIN 20,158,328 NON VOTES

Ratification of Rose, Snyder & Jacobs as Independent Auditors of the Company

87,172,994 FOR 591,637 AGAINST 1,973,919 ABSTAIN

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses